Dr. Reddy's inks collaboration deal with Bio-Thera to develop and commercialize proposed biosimilar candidates of J&J's Stelara and Simponi in Southeast Asia.

The legislation, SB 2385, filed by state Sen. David Koehler, D-Peoria, would curb PBM abuses by stopping steering, mandating ...

Between 2009 and 2021, nearly 838 pharmacies closed in Illinois, according to researchers at Southern Illinois University in ...

REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the "Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Celltrion, Inc., today announced that STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) has been added to ...

Hyderabad: Dr Reddy's Labs (DRL) on Wednesday said its subsidiary, Dr Reddy's Labs SA, entered into commercialisation and ...

HYDERABAD: Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and ...

Bio-Thera Solutions and Dr. Reddy’s partner for biosimilar commercialization in Southeast Asia, expanding access to critical treatments.

With this partnership, they aim to enhance access to affordable treatments for patients suffering from autoimmune diseases ...

Bio-Thera and Dr. Reddy's partner for biosimilar commercialization in Southeast Asia, expanding access to affordable ...